AVMR - AVRA Medical Robotics, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.3100
+0.0292 (+10.42%)
At close: 10:11AM EDT
Stock chart is not supported by your current browser
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
  • Short Term
    2W - 6W
  • Mid Term
    6W - 9M
  • Long Term
    9M+
Previous Close0.2808
Open0.3100
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.3100 - 0.3100
52 Week Range0.1700 - 2.9600
Volume100
Avg. Volume2,549
Market Cap6.853M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.0930
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • GlobeNewswire

      AVRA Medical Robotics (OTC: AVMR) CEO Barry Cohen Acquires 1,000,000 Shares of Company Stock

      AVRA Medical Robotics, Inc. (the “Company”) (AVMR), an artificial intelligence company building a fully autonomous medical robotic system combining artificial intelligence, machine learning and proprietary software, today announces that its Chairman & CEO, Barry Cohen, has increased his stake in the company by approximately 5% by purchasing an additional 1,000,000 common shares of AVRA stock. The shares will be restricted.

    • GlobeNewswire

      AVRA Medical Robotics Clears Debt

      ORLANDO, Fla., Feb. 03, 2020 -- AVRA Medical Robotics, Inc. (the “Company”) (OTCQB: AVMR), a medical software and artificial intelligence company building a fully autonomous.

    • GlobeNewswire

      AVRA Medical Robotics Attends J.P. Morgan Healthcare Conference

      ORLANDO, Fla., Jan. 17, 2020 -- AVRA Medical Robotics, Inc. (the “Company”) (OTCQB: AVMR), a medical software and artificial intelligence company that is in the process of.

    • GlobeNewswire

      AVRA Medical Robotics Appoints Two World Renowned Professionals to Chair its Medical and Scientific Advisory Boards

      AVRA Medical Robotics, Inc. (the “Company”) (AVMR), an emerging company which is building a fully autonomous medical robotic system through the use of new technologies combining artificial intelligence, machine learning and proprietary software, announced today it has appointed Dr. Vipul Patel to Chair its Medical Advisory Board and Dr. Eytan Pollak to Chair the Scientific Advisory Board, effective immediately.

    • GlobeNewswire

      AVRA Medical Robotics Initiates Food and Drug Administration Approval Process

      The Company’s robot arm has already won approval in the EU and received the CE mark. The Company has begun implementing a quality and regulatory system that will serve as the foundation for US, Canadian, European, Australian, Japanese, and Brazilian market access for AVRA’s modern medical robotic system – a ground-breaking approach to medical robotics.

    • GlobeNewswire

      AVRA Medical Robotics Announces its Participation in 10th Annual Meeting of the Society of Robotic Surgery

      AVRA Medical Robotics, Inc. (the “Company”) (AVMR), an emerging company developing a proprietary software coded system that uses artificial intelligence and machine learning capabilities for the purpose of creating the next generation of fully autonomous medical robotic systems, announced today that its Chief Strategy Officer, D. Nikhil Shah, delivered a presentation at this year’s Annual Meeting of the Society of Robotic Surgery. Barry Cohen, Chairman and Chief Executive Officer of the Company, commented, “I was extremely pleased that we were able to share the AVRA story at this year’s meeting of the Society of Robotic Surgery.

    • GlobeNewswire

      AVRA Medical Robotics Announces Extension of Research Agreement with University of Central Florida

      As part of this research agreement, UCF engineering students under the direction of Electrical Engineering Professor Zhihua Qu, continue to assist AVRA with its research and development of autonomous medical robotics. AVRA’s robotics lab is located in Central Florida’s Research Park, in close proximity to UCF’s main campus.

    • GlobeNewswire

      AVRA Medical Robotics Appoints Timothy K. Duggins as Regulatory Consultant

      AVRA Medical Robotics, Inc. (the “Company”) (AVMR), an emerging company that is creating the next generation of autonomous surgical robotics through the use of technologies such as artificial intelligence, machine learning and proprietary medical software architecture, announced today that it has retained The Horizon Phoenix Group and its principal Mr. Timothy K. Duggins as a regulatory consultant. The company entered into a four-year contract to conduct regulatory work on behalf of AVRA. The Horizon Phoenix Group has commenced its services on behalf of AVRA and has since initiated a dialogue with the Food and Drug Administration (FDA), prepared and filed an application for AVRA’s fully autonomous surgical robotic system with the FDA.